Cannabis
Cansortium Announces Opening of its 14th Fluent™ Medical Marijuana Dispensary in Florida
Cansortium Inc. (“Cansortium” or the “Company”) (CSE: TIUM), a vertically-integrated, global provider of premium-quality medical cannabis operating under the Fluent brand, continues to expand its Florida retail footprint with the August 1 opening of a new Fluent dispensary in a prime location in New Port Richey, FL.
Cansortium’s Chief Executive Officer Jose Hidalgo noted, “As one of the first five licensed operators in Florida – the state with the fastest-growing medical marijuana patient population in the U.S. – we continue to capitalize on our first-mover position, executing our growth plan by steadily expanding our dispensary network to enhance access to our premium-quality Fluent cannabis products for medical marijuana patients across the state. We continue to expect to have 30 Florida locations opened or secured by the end of 2019 and are formulating plans for continued expansion in 2020. We believe we are in the final stages of obtaining licensing approvals from Florida’s Department of Health to commence cultivation at Phase 2 of our existing Tampa cultivation facility, which will nearly double our overall Florida production capacity. We expect this additional capacity to support the continued planned expansion of our Florida dispensary platform throughout the remainder of 2019 and into 2020.”
The new 3,260 square-foot New Port Richey dispensary, located at 5138 Deer Park Drive, is the Company’s 14th in Florida, with 16 more locations expected to be opened or secured by the end of 2019. The new dispensary is located on New Port Richey’s most-traveled road and will also serve residents in nearby Hudson, Port Richey, Bayonet Point, Tarpon Springs, Holiday, Beacon Square, and Elfers.
The Fluent brand continually strives to set the standard for premium quality, consistently-formulated cannabis products. Each of the Company’s Florida dispensaries carries a complete assortment of Fluent premium dried flower, and full spectrum concentrates and cartridges as well as creams, drops, capsules and suppositories. All Fluent products in the Company’s Florida dispensaries use high-quality cannabis that is cultivated, processed and packaged in our state-of-the-art Florida facilities in strict compliance with Florida regulations. For consumers, the sleek, modern dispensaries provide a warm, welcoming, professional environment, with private consultation rooms and knowledgeable staff who carefully guide patients in selecting the right products and carefully safeguard patient privacy.
For a complete list of FLUENT dispensary locations, current promotions and rewards programs and hours of operation, or to place an online order for home delivery anywhere in Florida, visit https://getfluent.com/.
Cannabis
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
Cannabis
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
Cannabis
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Cannabis2 weeks ago
Right on Brands Announces Major Product Line Expansion via HONEY® Brands
-
transfer2 weeks ago
IMC to transfer its Oranim Pharmacy shares back to the seller
-
Cannabis1 week ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
CCELL®2 weeks ago
CCELL Launches Environmentally Conscious Eco Star AIO Vaporizer
-
Innocan7 days ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf7 days ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis6 days ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care